Skip to nav Skip to content

News

October 30, 2019

 ALL ARTICLES

Why Fighting AMR May Be a Hard Sell on Capitol Hill, and more ID in the News

National Journal spoke with Amanda Jezek, IDSA’s senior vice president of public policy and government relations, on why antibiotics are a politically difficult sell on Capitol Hill. 

According to Jezek, there is growing understanding among lawmakers about the antibiotic-resistance crisis, but the issue hasn’t had the attention of many large patient-driven advocacy organizations. “Some of that is probably because when patients get antibiotic-resistant infections, they’re acute,” she said. “Either they are lucky, and they get a drug and they are successfully treated and they are able to move on and go about their lives ... or, if there aren’t any antibiotics to treat them, they pass fairly quickly from these acute infections.”

This is just one of the news pieces that IDSA and our member spokespersons contributed to, in addition to others in the pipeline. Follow us on Twitter, LinkedIn and Facebook to see the latest news and opinion pieces featuring IDSA, HIVMA and our members.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.